Park, Yoon Jung Park, Je-Wook Yu, Hee Tae Kim, Tae-Hoon Uhm, Jae-Sun Joung, Boyoung Lee, Moon-Hyoung Pak, Hui-Nam
Published in
Heart (British Cardiac Society)
The risk of recurrence after atrial fibrillation (AF) catheter ablation (AFCA) is higher in women than in men. However, it is unknown whether a sex difference exists in antiarrhythmic drug (AAD) responsiveness among patients with recurrence. Among 2999 consecutive patients (26.5% women, 58.3±10.9 years old, 68.1% paroxysmal AF) who underwent de nov...
Hayek, Ahmad Marquis-Gravel, Guillaume
Published in
Heart (British Cardiac Society)
Raisi-Estabragh, Zahra Cooper, Jackie Bethell, Mae S McCracken, Celeste Lewandowski, Adam J Leeson, Paul Neubauer, Stefan Harvey, Nicholas C Petersen, Steffen E
Published in
Heart (British Cardiac Society)
To examine associations of birth weight with clinical and imaging indicators of cardiovascular health and evaluate mechanistic pathways in the UK Biobank. Competing risk regression was used to estimate associations of birth weight with incident myocardial infarction (MI) and mortality (all-cause, cardiovascular disease, ischaemic heart disease, MI)...
Zeitouni, Michel Sulman, David Silvain, Johanne Kerneis, Mathieu Guedeney, Paul Barthelemy, Olivier Brugier, Delphine Sabouret, Pierre Procopi, Niki Collet, Jean-Philippe
...
Published in
Heart (British Cardiac Society)
To determine if the changes in the European Society Cardiology/European Atherosclerotic Society (ESC/EAS) guidelines improved the identification for primary prevention therapy in young adults at risk of a premature myocardial infarction. Patients admitted for a first ST-segment elevation myocardial infarction (STEMI) in the ePARIS registry (n=2757)...
Savage, Henry Oluwasefunmi Dimarco, Anthony David Li, Brian Langley, Samantha Hardy-Wallace, Amy Barbagallo, Rossella Dungu, Jason N
Published in
Heart (British Cardiac Society)
The management of heart failure with a reduced ejection fraction is a true success story of modern medicine. Evidence from randomised clinical trials provides the basis for an extensive catalogue of disease-modifying drug treatments that improve both symptoms and survival. These treatments have undergone rigorous scrutiny by licensing and guideline...
Balasubramanian, R Navin Mills, Greg B Wilkinson, Chris Mehran, Roxana Kunadian, Vijay
Published in
Heart (British Cardiac Society)
We summarise the international guidelines surrounding risk stratification as well as discuss new emerging data for future development of a new risk model in the management of patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS). NSTE-ACS accounts for the bulk of acute coronary syndrome presentations in the UK, but management st...
Rasmussen, Laust Dupont Winther, Simon Karim, Salma Raghad Westra, Jelmer Kirk Johansen, Jane Søndergaard, Hanne Maare Hammid, Osama Sevestre, Emelyne Onuma, Yoshinobu Nyegaard, Mette
...
Published in
Heart (British Cardiac Society)
Validation studies of the 2019 European Society of Cardiology pretest probability model (ESC-PTP) for coronary artery disease (CAD) report that 35%-40% of patients have low pretest probability (ESC-PTP 5% to
Robijn, Annelies L Filion, Kristian B Woodward, Mark Hsu, Benjumin Chow, Clara K Pearson, Sallie-Anne Jorm, Louisa Falster, Michael O Havard, Alys
Published in
Heart (British Cardiac Society)
To determine the comparative effectiveness of postdischarge use of varenicline versus prescription nicotine replacement therapy (NRT) patches for the prevention of recurrent cardiovascular events and mortality and whether this association differs by sex. Our cohort study used routinely collected hospital, pharmaceutical dispensing and mortality dat...
Gaertner, Jan Fusi-Schmidhauser, Tanja Stock, Stephanie Siemens, Waldemar Vennedey, Vera
Published in
Heart (British Cardiac Society)
For the treatment of breathlessness in heart failure (HF), most textbooks advocate the use of opioids. Yet, meta-analyses are lacking. A systematic review was performed for randomised controlled trials (RCTs) assessing effects of opioids on breathlessness (primary outcome) in patients with HF. Key secondary outcomes were quality of life (QoL), mort...
Krieger, Eric V Burke, Christopher R McCabe, James M
Published in
Heart (British Cardiac Society)